Christopher Hite Insider Trading
Get free email notifications about insider trading for Christopher Hite.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Christopher Hite. Christopher Hite is a Director in ACCELERON PHARMA INC ($XLRN) and a EVP & Vice Chairman in Royalty Pharma plc ($RPRX).
Address: 128 SIDNEY STREET CAMBRIDGE 02139 MA
Companies in which Christopher Hite is an Insider
ACCELERON PHARMA INC
Trading Symbol: XLRNIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Christopher Hite: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 05 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Royalty Pharma plc
Trading Symbol: RPRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Christopher Hite: EVP & Vice Chairman
Holdings: 70,000 shares
Latest Transaction: Mar 25 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Christopher Hite
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 25 2021 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Option Exercise | S | 0.00 | 31,959 | 0 | 30,541 | |
Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Option Exercise | A | 0.00 | 116,100 | 0 | 116,100 | |
Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Option Exercise | A | 0.00 | 62,500 | 0 | 62,500 | |
Jun 23 2020 | RPRX | Royalty Pharma plc | Hite Christopher | EVP & Vice Chairman | Buy | P | 28.00 | 70,000 | 1,960,000 | 70,000 | 0 to 70 K |
Jun 05 2020 | XLRN | ACCELERON PHARMA I ... | Hite Christopher | Director | Option Exercise | A | 92.09 | 10,267 | 945,488 | 10,267 | |
Jun 05 2020 | XLRN | ACCELERON PHARMA I ... | Hite Christopher | Director | Option Exercise | A | 92.09 | 10,267 | 945,488 | 10,267 |